Rathbones' head of collectives research Mona Shah asks if precision medicine is a reality or just wishful thinking.
In the late 1990s, advances in research and development (R&D) promised to revolutionise the pharmaceutical industry. Scientists were on the cusp of mapping the human genome, which is the DNA 'genetic...
Added to MSCI Emerging Markets index
Carbon tool will be rolled out to all its fund managers
Everyone should be held to account
TER of 0.55%
Struggled to attract new investment